Research
Hormonal
GLP-1 receptor agonists (GLP-1RAs) have proven efficacy in glucoregulation and weight loss.
Practitioners can consider GLP-1RAs as effective treatment options for managing diabetes and obesity.
StrongSupportsmedium confidence
Considering its proven efficacy in glucoregulation and weight loss, GLP-1 receptor agonists (GLP-1RAs) have emerged as a revolutionary breakthrough in the arena of diabetes management and weight control.
Why this rating
The claim is based on established pharmacological effects mentioned in the abstract.
Source
Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges
Xianxian Huang et al. · Journal of Endocrinology · 2024
reviewCited 16×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →